-
1
-
-
0027323646
-
Phase I clinical and pharmacologic study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempts at dose intensification using recombinant granulocyte colony stimulating factors
-
Saltz L, Sirott M, Young C et al. Phase I clinical and pharmacologic study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempts at dose intensification using recombinant granulocyte colony stimulating factors. J Natl Cancer Inst 1993;85:1499-1507.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 1499-1507
-
-
Saltz, L.1
Sirott, M.2
Young, C.3
-
2
-
-
0027454410
-
Phase I and pharmacokinetic study of topotecan, a new topoisomerase I inhibitor
-
Verweij J, Lund B, Beijnen J et al. Phase I and pharmacokinetic study of topotecan, a new topoisomerase I inhibitor. Ann Oncol 1993;4:673-678.
-
(1993)
Ann Oncol
, vol.4
, pp. 673-678
-
-
Verweij, J.1
Lund, B.2
Beijnen, J.3
-
3
-
-
0026537874
-
Phase I and pharmacologic study of topotecan: A novel topoisomerase I inhibitor
-
Rowinsky EK, Grochow LB, Hendricks CB et al. Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor. J Clin Oncol 1992;10:647-656.
-
(1992)
J Clin Oncol
, vol.10
, pp. 647-656
-
-
Rowinsky, E.K.1
Grochow, L.B.2
Hendricks, C.B.3
-
4
-
-
0028090410
-
Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia
-
Rowinsky EK, Adjei AA, Donehower RC et al. Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia. J Clin Oncol 1994;12:2193-2203.
-
(1994)
J Clin Oncol
, vol.12
, pp. 2193-2203
-
-
Rowinsky, E.K.1
Adjei, A.A.2
Donehower, R.C.3
-
5
-
-
0027501999
-
Phase I study of topotecan, a new topoisomerase I inhibitor in patients with refractory or relapsed acute leukemia
-
Kantarjian HM, Beran M, Ellis A et al. Phase I study of topotecan, a new topoisomerase I inhibitor in patients with refractory or relapsed acute leukemia. Blood 1993;81:1146-1151.
-
(1993)
Blood
, vol.81
, pp. 1146-1151
-
-
Kantarjian, H.M.1
Beran, M.2
Ellis, A.3
-
6
-
-
0000760112
-
Camptothecins
-
Chabner BA, Longo DL, eds. Philadelphia, PA: Lippincott Raven Publishers
-
Takimoto CH, Arbuck S. Camptothecins. In: Chabner BA, Longo DL, eds. Cancer Chemotherapy and Biotherapy: Principals and Practice, 2nd ed. Philadelphia, PA: Lippincott Raven Publishers, 1996:463-484.
-
(1996)
Cancer Chemotherapy and Biotherapy: Principals and Practice, 2nd Ed.
, pp. 463-484
-
-
Takimoto, C.H.1
Arbuck, S.2
-
7
-
-
9244247616
-
Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma
-
Kudelka AP, Tresukosol D, Edwards CL et al. Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma. J Clin Oncol 1996;14:1552-1557.
-
(1996)
J Clin Oncol
, vol.14
, pp. 1552-1557
-
-
Kudelka, A.P.1
Tresukosol, D.2
Edwards, C.L.3
-
8
-
-
10544229791
-
Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: Results of a large European phase II study
-
Creemers GJ, Bolis G, Gore M et al. Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study. J Clin Oncol 1996:14:3056-3061.
-
(1996)
J Clin Oncol
, vol.14
, pp. 3056-3061
-
-
Creemers, G.J.1
Bolis, G.2
Gore, M.3
-
9
-
-
0000391321
-
Efficacy of topotecan in advanced epithelial ovarian cancer after failure of platinum and paclitaxel: International topotecan study group trial
-
Gordon A, Bookman M, Malmstrom H et al. Efficacy of topotecan in advanced epithelial ovarian cancer after failure of platinum and paclitaxel: international topotecan study group trial. Proc Am Soc Clin Oncol 1996;15:282.
-
(1996)
Proc Am Soc Clin Oncol
, vol.15
, pp. 282
-
-
Gordon, A.1
Bookman, M.2
Malmstrom, H.3
-
10
-
-
0030900145
-
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer
-
ten Bokkel Huinink W, Gore M, Carmichael J et al. Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. J Clin Oncol 1997:15:2183-2193.
-
(1997)
J Clin Oncol
, vol.15
, pp. 2183-2193
-
-
Ten Bokkel Huinink, W.1
Gore, M.2
Carmichael, J.3
-
11
-
-
0029934111
-
A phase II trial of topotecan in patients with unresectable and untreated pancreatic cancer
-
O'Reilly S, Donehower RC, Rowinsky EK et al. A phase II trial of topotecan in patients with unresectable and untreated pancreatic cancer. Anti-Cancer Drugs 1996;7:410-414.
-
(1996)
Anti-Cancer Drugs
, vol.7
, pp. 410-414
-
-
O'Reilly, S.1
Donehower, R.C.2
Rowinsky, E.K.3
-
12
-
-
0000626027
-
A phase II trial of topotecan as salvage therapy in epithelial ovarian cancer
-
Armstrong D, Rowinsky E, Donehower R et al. A phase II trial of topotecan as salvage therapy in epithelial ovarian cancer. Proc Am Soc Clin Oncol 1995;12:275.
-
(1995)
Proc Am Soc Clin Oncol
, vol.12
, pp. 275
-
-
Armstrong, D.1
Rowinsky, E.2
Donehower, R.3
-
13
-
-
15844424667
-
Phase I and pharmacologic study of topotecan in patients with impaired hepatic function
-
O'Reilly S, Rowinsky EK, Slichenmeyer W et al. Phase I and pharmacologic study of topotecan in patients with impaired hepatic function. J Natl Cancer Inst 1996;88:817-824.
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 817-824
-
-
O'Reilly, S.1
Rowinsky, E.K.2
Slichenmeyer, W.3
-
14
-
-
0029966916
-
Phase I and pharmacologic study of topotecan in patients with impaired renal function
-
O'Reilly S, Rowinsky EK, Slichenmeyer W et al. Phase I and pharmacologic study of topotecan in patients with impaired renal function. J Clin Oncol 1996; 14:3062-3073.
-
(1996)
J Clin Oncol
, vol.14
, pp. 3062-3073
-
-
O'Reilly, S.1
Rowinsky, E.K.2
Slichenmeyer, W.3
-
15
-
-
0031456165
-
Life threatening myelosuppression in patients with renal impairment receiving topotecan
-
O'Reilly S, Armstrong DK, Grochow LB. Life threatening myelosuppression in patients with renal impairment receiving topotecan. Gynecol Oncol 1997;67:329-330.
-
(1997)
Gynecol Oncol
, vol.67
, pp. 329-330
-
-
O'Reilly, S.1
Armstrong, D.K.2
Grochow, L.B.3
-
16
-
-
0024440650
-
Carboplatin dosage: Prospective evaluation of a simple formula based on renal function
-
Calvert AH, Newell DR, Gumbrell LA et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989;7:1748-1756.
-
(1989)
J Clin Oncol
, vol.7
, pp. 1748-1756
-
-
Calvert, A.H.1
Newell, D.R.2
Gumbrell, L.A.3
-
17
-
-
0028036827
-
American Society of Clinical Oncology recommendations for the use of hematopoietic colony-stimulating factors:evidence based clinical practice guidelines
-
American Society of Clinical Oncology. American Society of Clinical Oncology recommendations for the use of hematopoietic colony-stimulating factors:evidence based clinical practice guidelines. J Clin Oncol 1994; 12:2471-2508.
-
(1994)
J Clin Oncol
, vol.12
, pp. 2471-2508
-
-
-
18
-
-
0344405536
-
Update of recommendations for the use of hematopoietic colony stimulating factors: Evidence based clinical practice guidelines
-
American Society of Clinical Oncology. Update of recommendations for the use of hematopoietic colony stimulating factors: evidence based clinical practice guidelines. J Clin Oncol 1996;14:1957-1960.
-
(1996)
J Clin Oncol
, vol.14
, pp. 1957-1960
-
-
-
19
-
-
0026603461
-
Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer
-
Jodrell DI, Egorin MJ, Canetta RM et al. Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. J Clin Oncol 1992;10:520-528.
-
(1992)
J Clin Oncol
, vol.10
, pp. 520-528
-
-
Jodrell, D.I.1
Egorin, M.J.2
Canetta, R.M.3
-
20
-
-
0015674428
-
Creatinine clearance: Bedside estimate
-
Jeliffe RW. Creatinine clearance: bedside estimate. Ann Intern Med 1973;79:604-605.
-
(1973)
Ann Intern Med
, vol.79
, pp. 604-605
-
-
Jeliffe, R.W.1
-
21
-
-
0016916438
-
Prediction of creatinine clearance from serum creatinine
-
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
-
(1976)
Nephron
, vol.16
, pp. 31-41
-
-
Cockcroft, D.W.1
Gault, M.H.2
|